.
BNTC financial statements
* Numbers in thousands
Year |
2020 | 2021 | TTM |
---|---|---|---|
Capitalization * |
7 659 | 3 574 | 2 400 |
EV * |
-1 950 | -15 982 | -15 982 |
Stock price $ |
7.5 | 3.5 | 2.35 |
Number of shares * |
1 021 | 1 021 | 1 021 |
EPS |
-8,10 | -13,59 | -13,59 |
Revenue * |
97 | 59 | 59 |
Net income * |
-8 274 | -13 882 | -13 882 |
Operating profit * |
-8 281 | -13 596 | -13 596 |
Total liabilities * |
1 349 | 1 369 | 1 369 |
Net debt * |
-9 396 | -19 556 | -19 556 |
Total assets * |
11 587 | 21 379 | 21 379 |
Equity * |
10 238 | 20 010 | 20 010 |
Cash and investments * |
9 801 | 19 769 | 19 769 |
Over the past 10 years, the maximum capitalization of Benitec Biopharma Inc. is 7 659, the minimum is 3 574. Maximum net income 0, Minimum net income -13 882. The maximum price of BNTC shares is 7.5, the minimum price is 3.5.
.
BNTC valuation
Year |
2020 | 2021 | TTM |
---|---|---|---|
P/E |
-0,93 | -0,26 | -0,17 |
P/B |
0,75 | 0,18 | 0,12 |
P/S |
78,96 | 60,58 | 40,67 |
E/P |
-108% | -388% | -578% |
P/FCF |
-1,00 | -0,27 | -0,18 |
.
BNTC profitability
Year |
2020 | 2021 | TTM |
---|---|---|---|
ROE |
-81% | -69% | |
ROA |
-71% | -65% | |
ROIC |
-79% | -68% |